Literature DB >> 15530559

Deregulation of the cell cycle by the Epstein-Barr virus.

Jenny O'Nions1, Martin J Allday.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530559     DOI: 10.1016/S0065-230X(04)92006-4

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  11 in total

1.  Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma.

Authors:  Hai-De Qin; Yin Yao Shugart; Jin-Xin Bei; Qing-Hua Pan; Lina Chen; Qi-Sheng Feng; Li-Zhen Chen; Wei Huang; Jian Jun Liu; Timothy J Jorgensen; Yi-Xin Zeng; Wei-Hua Jia
Journal:  Cancer Res       Date:  2011-03-02       Impact factor: 12.701

2.  Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53.

Authors:  Jenny O'Nions; Abigail Turner; Richard Craig; Martin J Allday
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

3.  Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.

Authors:  Maria Leao; Emma Anderton; Mark Wade; Kiran Meekings; Martin J Allday
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

Review 4.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

5.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

6.  Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.

Authors:  Fuming Yi; Abhik Saha; Masanao Murakami; Pankaj Kumar; Jason S Knight; Qiliang Cai; Tathagata Choudhuri; Erle S Robertson
Journal:  Virology       Date:  2009-04-24       Impact factor: 3.616

7.  Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts.

Authors:  Yongming Dai; Yunlian Tang; Fei He; Yang Zhang; Ailan Cheng; Runliang Gan; Yimou Wu
Journal:  Virol J       Date:  2012-03-30       Impact factor: 4.099

8.  Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.

Authors:  Abhik Saha; Sabyasachi Halder; Santosh K Upadhyay; Jie Lu; Pankaj Kumar; Masanao Murakami; Qiliang Cai; Erle S Robertson
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

Review 9.  How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?

Authors:  Martin J Allday
Journal:  Semin Cancer Biol       Date:  2009-07-25       Impact factor: 15.707

10.  Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.

Authors:  Michael J McClellan; C David Wood; Opeoluwa Ojeniyi; Tim J Cooper; Aditi Kanhere; Aaron Arvey; Helen M Webb; Richard D Palermo; Marie L Harth-Hertle; Bettina Kempkes; Richard G Jenner; Michelle J West
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.